Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Xeris Biopharma Holdings Inc (NASDAQ: XERS) closed at $3.24 in the last session, up 1.25% from day before closing price of $3.20. In other words, the price has increased by $1.25 from its previous closing price. On the day, 1.32 million shares were traded. XERS stock price reached its highest trading level at $3.325 during the session, while it also had its lowest trading level at $3.225.
Ratios:
We take a closer look at XERS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.29 and its Current Ratio is at 1.79.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.Craig Hallum initiated its Buy rating on August 28, 2023, with a $4.50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Schmid John P. bought 4,515 shares for $2.25 per share. The transaction valued at 10,147 led to the insider holds 25,200 shares of the business.
Schmid John P. bought 4,285 shares of XERS for $10,134 on Aug 09 ’24. The Director now owns 20,685 shares after completing the transaction at $2.37 per share. On May 10 ’24, another insider, Schmid John P., who serves as the Director of the company, bought 5,400 shares for $1.91 each. As a result, the insider paid 10,314 and bolstered with 16,400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 483022400 and an Enterprise Value of 684586944. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.58. Its current Enterprise Value per Revenue stands at 3.654 whereas that against EBITDA is -20.706.
Stock Price History:
The Beta on a monthly basis for XERS is 1.81, which has changed by 0.29032254 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $3.87, while it has fallen to a 52-week low of $1.69. The 50-Day Moving Average of the stock is -2.78%, while the 200-Day Moving Average is calculated to be 22.82%.
Shares Statistics:
According to the various share statistics, XERS traded on average about 1.64M shares per day over the past 3-months and 1552000 shares per day over the past 10 days. A total of 149.00M shares are outstanding, with a floating share count of 138.51M. Insiders hold about 7.09% of the company’s shares, while institutions hold 43.72% stake in the company. Shares short for XERS as of 1735603200 were 10188099 with a Short Ratio of 6.21, compared to 1732838400 on 9908169. Therefore, it implies a Short% of Shares Outstanding of 10188099 and a Short% of Float of 7.000000000000001.
